XML 61 R42.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of loss before income taxes
Loss before income before income taxes are as follows (in thousands):
Year ended
December 31,
2025
Year ended
December 31,
2024
United Kingdom$(42,544)$(27,510)
United States(24,053)(32,833)
Other foreign(36)(884)
Loss before income taxes$(66,633)$(61,227)
Schedule of components of income tax benefit (expense)
The components of income tax benefit are as follows (in thousands):
Year ended
December 31,
2025
Year ended
December 31,
2024
Current income tax benefit/(expense):
United States$— $(70)
Other Foreign(9)(22)
Deferred income tax benefit:
United States184 136 
Total income tax benefit$175 $44 
Schedule of Reconciliation to the effective tax rate
A reconciliation of the U.K. statutory income tax rate to the Company's effective tax rate as reflected in the consolidated financial statements is as follows:
Year ended December 31, 2025Year ended December 31, 2024
Statutory tax rate$16,658 25.00 %$15,307 25.00 %
Increase (decreases) resulting from:
Foreign tax effects-United States:
Changes in valuation allowance(6,122)(9.17)(4,002)(6.54)
Share-based compensation(118)(0.18)— — 
Non-taxable or non-deductible items(506)(0.76)(3,505)(5.73)
Foreign tax effects-Switzerland:
Share-based compensation(2)— (30)(0.05)
Effect of change in tax laws or rates enacted in the current period598 0.90 721 1.18 
Tax credits(81)(0.12)(3,501)(5.72)
Changes in valuation allowance(7,513)(11.27)(2,116)(3.46)
Non-taxable or non-deductible items(2,496)(3.75)(46)(0.06)
Other adjustments(243)(0.37)(2,784)(4.55)
Effective tax rate$175 0.28 %$44 0.07 %
Schedule of significant components of deferred tax assets and liabilities Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
December 31,
2025
December 31,
2024
Deferred tax assets:
Net operating loss carryforwards$40,691 $26,040 
Research and development credit carryforwards313 47 
Share based compensation4,190 4,753 
Lease liability2,965 3,156 
Accruals28 — 
Intangible amortization459 452 
Capitalized Research and Development expenditure4,765 6,185 
Other62 10 
Gross deferred tax asset53,473 40,643 
Valuation allowance(46,266)(30,830)
Net deferred tax assets7,207 9,813 
Deferred tax liabilities:  
Depreciation(1,130)(1,815)
Right-of-use lease asset(1,060)(1,149)
Undistributed earnings of subsidiaries(1,339)(1,248)
Intangible assets(3,932)(6,039)
Net deferred tax liabilities(7,461)(10,251)
Total deferred tax, net$(254)$(438)
Schedule of changes in the valuation allowance for deferred tax assets
Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2025 and 2024 related primarily to the increase in net operating loss and credit carryforwards, and were as follows:
Year ended
December 31,
2025
Year ended
December 31,
2024
Valuations allowance at beginning of year$30,830 $25,057 
Changes in valuation allowance arising from in-year additions— — 
Increases recorded to income tax provision13,634 6,123 
Foreign exchange translation1,802 (350)
Valuation allowance at end of year$46,266 $30,830